[1]
Kandefer, N., Jaremek, A., Kępa, J., Wyszkowski, M., Grabarczyk, A., Pawlak, A., Grad, S., Gregorek, P., Gregorek, M., Loryś, L. and Klimczak, K. 2023. Modafinil. Armodafinil. The use of eugeroics in assisting the treatment of depression, bipolar disorder, and schizophrenia. Benefits, drawbacks, and adverse effects. Journal of Education, Health and Sport. 43, 1 (Aug. 2023), 264–285. DOI:https://doi.org/10.12775/JEHS.2023.43.01.020.